(Q37174049)

18 August 2017

1 reference

title

Diagnostic and treatment challenges of chronic fatigue syndrome: role of immediate-release methylphenidate (English)

1 reference

18 August 2017

0 references

chronic fatigue syndrome

1 reference

based on heuristic

inferred from title

author name string

José Ramón Valdizán Usón

series ordinal

1

1 reference

18 August 2017

María Angeles Idiazábal Alecha

series ordinal

2

1 reference

18 August 2017

language of work or name

1 reference

1 June 2008

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

917-927

1 reference

Chronic fatigue in primary care. Prevalence, patient characteristics, and outcome

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Population based study of fatigue and psychological distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Chronic fatigue syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Epidemiology of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

A community-based study of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

The economic impact of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

An examination of the working case definition of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Functional somatic syndromes: one or many?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

What causes chronic fatigue syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Neuroendocrine aspects of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Researchers find genetic clues to chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

The challenge of integrating disparate high-content data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Gene expression profile exploration of a large dataset on chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Challenges for molecular profiling of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Objective evidence of cognitive complaints in Chronic Fatigue Syndrome: a BOLD fMRI study of verbal working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Neuropsychological functioning in chronic fatigue syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Interventions for the treatment and management of chronic fatigue syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Neuropsychological deficits in patients with chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Attention and information processing efficiency in patients with Chronic Fatigue Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Memory, attention, and executive function in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Cognitive functioning in patients with chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: new trends and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Effects of methylphenidate on working memory components: influence of measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Use of methylphenidate in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Palliative Uses of Methylphenidate in Patients With Cancer: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

Does methylphenidate reduce the symptoms of chronic fatigue syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.917

21 January 2018

Identifiers

DOI

10.1586/14737175.8.6.917

1 reference

18 August 2017

1 reference